[1] TOWFIGHI A, SAVER JL.Stroke declines from third to fourth leading cause of death in the United States: historical perspective and challenges ahead[J]. Stroke, 2011, 42(8): 2351. doi: 10.1161/STROKEAHA.111.621904
[2] JI R, SCHWAMM LH, PERVEZ MA, et al. Ischemic stroke and transient ischemic attack in young adults: risk factors, diagnostic yield, neuroimaging, and thrombolysis[J]. JAMA Neurol, 2013, 70(1): 51. doi: 10.1001/jamaneurol.2013.575
[3] THOMAS MR, LIP GYH.Novel risk markers and risk assessments for cardiovascular disease[J]. Circulation Res, 2017, 120(1): 133. doi: 10.1161/CIRCRESAHA.116.309955
[4] HANNIBAL L, BLOM HJ.Homocysteine and disease: causal associations or epiphenomenons?[J]. Mol Aspects Med, 2016, 53: 36.
[5] JIANG XG, LIN Y, LI YS.Correlative study on risk factors of depression among acute stroke patients[J]. Eur Rev Med Pharmacol Sci, 2014, 18(9): 1315.
[6] BALDASSARRE D, AMATO M, BONDIOLI A, et al. Carotid artery intima-media thickness measured by ultrasonography in normal clinical practice correlates well with atherosclerosis risk factors[J]. Stroke, 2000, 31(10): 2426. doi: 10.1161/01.STR.31.10.2426
[7] ELKIND MS, CHENG J, BODEN-ALBALA B, et al. Elevated white blood cell count and carotid paque thickness: the northern manhattan stroke study[J]. Stroke, 2001, 32(4): 842. doi: 10.1161/01.STR.32.4.842
[8] SIMON A, GARIEPY J, CHIRONI G, et al. Intima-media thickness: a new tool for diagnosis and treatment of cardiovascular risk[J]. J Hypertens, 2002, 20(2): 159. doi: 10.1097/00004872-200202000-00001
[9] BARTON M.Postmenopausal oestrogen replacement therapy and atherosclerosis: can current compounds provide cardiovascular protection?[J]. Expert Opin Investig Drugs, 2001, 10(5): 789. doi: 10.1517/13543784.10.5.789
[10] MAGNANI G, DEMOLA MA, FAVA C, et al. From vulnerable plaque to vulnerable patient[J]. G Ital Cardiol, 2010, 11(3): 6S.
[11] PRETORIUS E, ROOY MJV.Obesity, hypertension and hypercholesterolemia as risk factors for atherosclerosis leading to ischemic events[J]. Curr Med Chem, 2014, 21(19): 2121. doi: 10.2174/0929867321666131227162950
[12] SKOVIEROVÁ H, VIDOMANOVÁ E, SILVIA M, et al. The molecular and cellular effect of homocysteine metabolism imbalance on human health[J]. Int J Mol Sci, 2016, 17(10): 1733. doi: 10.3390/ijms17101733
[13] GREGOIRE SM, SCHEFFLER G, JAGER HR, et al. Strictly lobar microbleeds are associated with executive impairment in patients with ischemic stroke or transient ischemic attack[J]. Stroke, 2013, 44(5): 1267. doi: 10.1161/STROKEAHA.111.000245
[14] MIWA K, TANAKA M, OKAZAKI S, et al. Relations of blood inflammatory marker levels with cerebral microbleeds[J]. Stroke, 2011, 42(11): 3202. doi: 10.1161/STROKEAHA.111.621193
[15] DEVASIA AJ, JOY B, TAREY SD.Serum homocysteine as a risk factor for carotid intimal thickening in acute stroke: a cross sectional observational study[J]. Ann Indian Acad Neurol, 2016, 19(1): 48. doi: 10.4103/0972-2327.168633
[16] BREE AD, MENNEN LI, ZUREIK M, et al. Homocysteine is not associated with arterial thickness and stiffness in healthy middle-aged French volunteers[J]. Int J Cardiol, 2006, 113(3): 340.
[17] MEYE C, SCHUMANN J, WAGNER A, et al. Effects of homocysteine on the levels of caveolin-1 and eNOS in caveolae of human coronary artery endothelial cells[J]. Atherosclerosis, 2007, 190(2): 256. doi: 10.1016/j.atherosclerosis.2006.03.009
[18] ALBA FS, SERGI SB, ISAAC S, et al. Association between DNA methylation and coronary heart disease or other atherosclerotic events: a systematic review[J]. Atherosclerosis, 2017, 263: 325. doi: 10.1016/j.atherosclerosis.2017.05.022
[19] HUMPHREY LL, FU R, ROGERS K, et al. Homocysteine level and coronary heart disease incidence: a systematic review and meta-analysis[J]. Mayo Clin Proc, 2008, 83(11): 1203. doi: 10.4065/83.11.1203
[20] KRISHNA SM, DEAR A, CRAIG JM, et al. The potential role of homocysteine mediated DNA methylation and associated epigenetic changes in abdominal aortic aneurysm formation[J]. Atherosclerosis, 2013, 228(2): 295. doi: 10.1016/j.atherosclerosis.2013.02.019
[21] KIM JM, PARK KY, SHIN DW, et al. Relation of serum homocysteine levels to cerebral artery calcification and atherosclerosis[J]. Atherosclerosis, 2016, 254: 200. doi: 10.1016/j.atherosclerosis.2016.10.023
[22] CATENA C, COLUSSI GL, MARION UM, et al. Subclinical carotid artery disease and plasma homocysteine levels in patients with hypertension[J]. J Am Soc Hypertens, 2015, 9(3): 167. doi: 10.1016/j.jash.2014.12.020
[23] SARA A, HANNAH G, ELKIND MSV, et al. Elevated homocysteine and carotid plaque area and densitometry in the Northern Manhattan study[J]. Stroke, 2013, 44(2): 457. doi: 10.1161/STROKEAHA.112.676155